Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study.
Justin J SongNicholas J JacksonHelen ShangHenry M HondaKristin BoulierPublished in: Journal of cardiovascular pharmacology and therapeutics (2024)
Anticoagulation strategy in patients with cirrhosis and AF was associated with increased rate of hospital admission and ICU admission but not associated with increased risk of mortality or transfusion requirement.
Keyphrases
- atrial fibrillation
- left atrial
- oral anticoagulants
- catheter ablation
- emergency department
- direct oral anticoagulants
- left atrial appendage
- heart failure
- venous thromboembolism
- percutaneous coronary intervention
- healthcare
- intensive care unit
- cardiovascular events
- cardiac surgery
- risk factors
- type diabetes
- cardiovascular disease
- mechanical ventilation
- adverse drug
- metabolic syndrome
- sickle cell disease
- insulin resistance
- acute kidney injury
- adipose tissue